MedWatch

Orifarm expands headquarters following huge acquisition

Last year’s multimillion-euro deal with Takeda increased the employee count by 600 heads at pharmaceutical organization Orifarm. This, and ongoing growth plans, meant the company decided to expand its headquarters with the addition of a 6,600 square meter building.

Orifarm has begun work on a new, four-story building, located on the street from where the company has operated for 21 years | Photo: Orifarm / PR

It is now exactly two years since pharmaceutical organization Orifarm announced the acquisition of 110 drugs from Japanese firm Takeda for EUR 615m, a deal that was officially completed in March last year.

The record-breaking takeover, which included two Takeda factories, one in Danish city Hobro and another in Łyszkowice, Poland, catapulted family owned Orifarm to the upper echelons of Danish pharmaceutical companies – both financially and in terms of the market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs